[Pharmacological basis of therapeutic monitoring during the perinatal period (proceedings)].
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000378:metabolism / Q000627:therapeutic use*; D001724:Birth Weight; D002301:Cardiac Glycosides / Q000378:metabolism / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D013806:Theophylline / Q000378:metabolism / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D002301:Cardiac Glycosides; D013806:Theophylline
Bases pharmacologiques de la surveillance thérapeutique a la période périnatale.